Prevention of pro-depressant effect of l-arginine in the forced swim test by NG-nitro-l-arginine and [1H-[1,2,4]Oxadiazole[4,3-a]quinoxalin-1-one]

European Journal of Pharmacology

Volumn 554, Issue 2-3, 2007, Pages 150-154

  Ergün, Yusuf ^a   Ergün, Ufuk Güney Özer ^a  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

(Mouse); cGMP; Depression; Forced swimming; l arginine; Nitric oxide

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ANTIDEPRESSANT AGENT; ARGININE; CYCLIC GMP; DIMETHYL SULFOXIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SODIUM CHLORIDE; SOLVENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FORCED SWIMMING TEST; IMMOBILIZATION; MAJOR DEPRESSION; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

ANIMALS; ANTIDEPRESSIVE AGENTS; ARGININE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; GUANYLATE CYCLASE; MICE; MICE, INBRED BALB C; MOTOR ACTIVITY; NITRIC OXIDE SYNTHASE; NITROARGININE; OXADIAZOLES; QUINOXALINES; SWIMMING;

EID: 33845318214     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.09.067     Document Type: Article

References (25)

1. Da Silva G.L., Matteussi A.S., Dos Santos A.R.S., Calixto J.B., and Rodrigues A.L. Evidence for dual effects of nitric oxide in the forced swim test and in the tail suspension test in mice. NeuroReport 11 (2000) 3699-3702
2. Ergun Y., Ergun U.G.O., Orhan O.O., and Kucuk E. Co-administration of a nitric oxide synthase inhibitor and melatonin exerts an additive antidepressant-like effect in the mouse forced swim test. Med. Sci. Monit. 12 (2006) BR307-BR312
3. Galeotti N., Ghelardini C., Caldari B., and Bartolini A. Effect of potassium channel modulators in mouse forced swimming test. Br. J. Pharmacol. 126 (1999) 1653-1659
4. Garthwaite J. Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci. 14 (1991) 60-67
5. Garthwaite J., Southam E., Boulton C.L., Nielsen E.B., Schmidt K., and Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one. Mol. Pharmacol. 48 (1995) 184-188
6. Guo W., Todd K., Bourin M., Hascoet M., and Kouadio F. Additive effects of glyburide and antidepressants in the forced swimming test: evidence for the involvement of potassium channel blockade. Pharmacol. Biochem. Behav. 54 (1996) 725-730
7. Harkin A.J., Bruce K.H., Craft B., and Paul I.A. Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. Eur. J. Pharmacol. 372 (1999) 207-213
8. Heiberg I.L., Wegener G., and Rosenberg R. Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats. Behav. Brain Res. 134 (2002) 479-484
9. Inan S.Y., Yalcin I., and Aksu F. Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide mediated serotonin release and potassium channel modulation. Pharmacol. Biochem. Behav. 77 (2004) 457-464
10. Karolewicz B., Paul I.A., and Antkiewicz-Michaluk L. Effect of NOS inhibitor on forced swim test and neurotransmitters turnover in the mouse brain. Pol. J. Pharmacol. 53 (2001) 587-596
11. Kaster M.P., Ferreira P.K., Santos A.R.S., and Rodrigues A.L.S. Effects of potassium channel inhibitors in the forced swim test: possible involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway. Behav. Brain Res. 165 (2005) 204-209
12. Kendrick K.M., Guevara-Guzman R., Zorilla J., Hinton M.R., Broad K.D., Mimmack M., and Ohkura S. Formation of olfactory memories mediated by nitric oxide. Nature 388 (1997) 670-674
13. Lei S.Z., Pan Z.H., Aggarwal S.K., Chen H.S., Hartman J., Sucher N.J., and Lipton S.A. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 48 (1992) 69-75
14. Maj J., Rogoz Z., Skuza G., and Sowinska H. Effects of MK-801 and antidepressant drugs in the forced swimming tests in rats. Eur. J. Neuropsychopharmacol. 2 (1992) 37-41
15. Manzoni O., and Bockaert J. Nitric oxide synthase activity endogenously modulates NMDA receptors. J. Neurochem. 61 (1993) 368-370
16. Meguro H., Mori H., Araki K., Kushiya E., Kutsuwada T., Yamazaki M., Kumanishi T., Arakawa M., Sakimura K., and Mishina M. Functional characterization of a heteromeric NMDA receptor channel from cloned cDNAs. Nature 357 (1992) 70-74
17. Morris S.M. Arginine: beyond protein. Am. J. Clin. Nutr. 83 (2006) 508S-512S
18. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229 (1977) 327-336
19. Redrobe J.P., Pinot P., and Bourin M. The effect of the potassium channel activator, cromakalim, on antidepressant drugs in the forced swim test in mice. Fundam. Clin. Pharmacol. 10 (1996) 524-528
20. Skolnick P., Miller R., Young A., Boje K., and Trullas R. Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-d-aspartate receptor complex. Psychopharmacology (Berlin) 107 (1992) 489-496
21. Southam E., and Garthwaite J. The nitric oxide-cyclic GMP signaling pathway in rat brain. Neuropharmacology 32 (1993) 1267-1277
22. Synder S.H., and Bredt B.S. Nitric oxide as a neuronal messenger. Trends. Pharmacol. Sci. 12 (1991) 125-128
23. Trabace L., and Kendrick K.M. Nitric oxide can differentially modulate striatal neurotransmitter concentrations via soluble guanylate cyclase and peroxynitrite formation. J. Neurochem. 75 (2000) 1664-1674
24. Trullas R., and Skolnick P. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur. J. Pharmacol. 185 (1990) 1-10
25. Trullas R., Folio T., Young A., Miller R., Boje K., and Skolnick P. 1-aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models. Eur. J. Pharmacol. 203 (1991) 379-385